Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1989 Dec;33(12):2142–2143. doi: 10.1128/aac.33.12.2142

In vitro activities of cefcanel and some other cephalosporins against Pasteurella multocida.

E Holst 1, J Rollof 1, H Miörner 1
PMCID: PMC172837  PMID: 2619280

Abstract

Thirty-five strains of Pasteurella multocida from humans and animals were tested for susceptibility to five cephalosporins by a broth dilution method. Cefcanel showed high activity against all isolates (MIC and MBC, less than or equal to 0.64 micrograms/ml). The corresponding figure for cefaclor and cefuroxime was 2.56 micrograms/ml. Cefadroxil and cephalexin were the least active compounds tested.

Full text

PDF
2142

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brook I. Microbiology of human and animal bite wounds in children. Pediatr Infect Dis J. 1987 Jan;6(1):29–32. doi: 10.1097/00006454-198701000-00008. [DOI] [PubMed] [Google Scholar]
  2. Goldstein E. J., Citron D. M., Finegold S. M. Role of anaerobic bacteria in bite-wound infections. Rev Infect Dis. 1984 Mar-Apr;6 (Suppl 1):S177–S183. doi: 10.1093/clinids/6.supplement_1.s177. [DOI] [PubMed] [Google Scholar]
  3. Goldstein E. J., Citron D. M., Richwald G. A. Lack of in vitro efficacy of oral forms of certain cephalosporins, erythromycin, and oxacillin against Pasteurella multocida. Antimicrob Agents Chemother. 1988 Feb;32(2):213–215. doi: 10.1128/aac.32.2.213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Goldstein E. J., Citron D. M., Vagvolgyi A. E., Finegold S. M. Susceptibility of bite wound bacteria to seven oral antimicrobial agents, including RU-985, a new erythromycin: considerations in choosing empiric therapy. Antimicrob Agents Chemother. 1986 Apr;29(4):556–559. doi: 10.1128/aac.29.4.556. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Goldstein E. J., Citron D. M., Wield B., Blachman U., Sutter V. L., Miller T. A., Finegold S. M. Bacteriology of human and animal bite wounds. J Clin Microbiol. 1978 Dec;8(6):667–672. doi: 10.1128/jcm.8.6.667-672.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Nord C. E., Lindmark A., Persson I. Comparative antibacterial activity of the new cephalosporin cefcanel against anaerobic bacteria. Eur J Clin Microbiol Infect Dis. 1989 Jun;8(6):550–551. doi: 10.1007/BF01967478. [DOI] [PubMed] [Google Scholar]
  7. Oberhofer T. R. Characteristics and biotypes of Pasteurella multocida isolated from humans. J Clin Microbiol. 1981 Mar;13(3):566–571. doi: 10.1128/jcm.13.3.566-571.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Rollof J., Nordin-Fredriksson G., Holst E. Pasteurella multocida occurs in a high frequency in the saliva of pet dogs. Scand J Infect Dis. 1989;21(5):583–584. doi: 10.3109/00365548909037889. [DOI] [PubMed] [Google Scholar]
  9. Shikuma C. C., Overturf G. D. Antibiotic susceptibility of Pasteurella multocida. Eur J Clin Microbiol. 1985 Oct;4(5):518–519. doi: 10.1007/BF02014442. [DOI] [PubMed] [Google Scholar]
  10. Weber D. J., Wolfson J. S., Swartz M. N., Hooper D. C. Pasteurella multocida infections. Report of 34 cases and review of the literature. Medicine (Baltimore) 1984 May;63(3):133–154. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES